Smita I Negi1, Ian Greener2, Aashish Anand3, Samuel C Dudley2. 1. Section of Cardiology, Medstar Washington Hospital Center/Georgetown University, Washington, DC. 2. Lifespan Cardiovascular Institute and the Warren Alpert Medical School of Brown University, Providence, RI. 3. Department of Neurology, University of Maryland, Baltimore, MD.
Abstract
BACKGROUND: Inflammation and oxidative stress have been linked to the origin and persistence of atrial fibrillation (AF). CHADS-2 scoring system is a risk stratification schema well validated in prognostication of stroke in AF. We evaluated the association of markers of oxidative stress and inflammation with CHADS-2 scores in chronic AF patients. METHODS: CHADS-2 scores were calculated for 64 subjects with chronic AF. Serum markers of inflammation [C-reactive protein (hs-CRP), interleukin-6 (IL-6), interleukin 1β (IL-1β), tumor necrosis factor-α (TNF-α)] and of oxidative stress [Derivatives of reactive oxygen metabolites (DROMs) and isoprostanes (IsoPs)] were measured. RESULTS: Twenty subjects were categorized as 0 (no risk), 24 as 1 (intermediate risk) and 20 as 2 (severe risk) based on their CHADS-2 scores. High sensitivity-CRP (CHADS-2 0=40.0%, 1=70.0%, 2=90.0%; p=0.003) and DROMs (CHADS-2 0=45%, 1=78%, 2=80%; p=0.04) were positively associated with the CHADS-2 risk score. Subjects with intermediate to severe CHADS-2 risk retained significant associations with abnormal hs-CRP (OR: 5.3, 95%CI: 1.1-25.0) and DROMs (adjusted OR: 6.7, 95%CI: 1.2-38.8) after adjusting for gender and hypertension. In a multiple logistic interaction model, there was no significant interaction between hs-CRP and DROMs in their association with CHADS-2 risk categories (p=0.64). A biomarker risk-model, combining hs-CRP and DROMs, correlated well with the CHADS-2 risk categories (r= 0.49, p<0.001). CONCLUSIONS: A biomarker risk-model using a combination of hs-CRP and DROMs correlates well with CHADS-2 risk scores in chronic AF. Either or both of these markers may add predictive power to future stroke risk prediction models.
BACKGROUND:Inflammation and oxidative stress have been linked to the origin and persistence of atrial fibrillation (AF). CHADS-2 scoring system is a risk stratification schema well validated in prognostication of stroke in AF. We evaluated the association of markers of oxidative stress and inflammation with CHADS-2 scores in chronic AFpatients. METHODS: CHADS-2 scores were calculated for 64 subjects with chronic AF. Serum markers of inflammation [C-reactive protein (hs-CRP), interleukin-6 (IL-6), interleukin 1β (IL-1β), tumor necrosis factor-α (TNF-α)] and of oxidative stress [Derivatives of reactive oxygen metabolites (DROMs) and isoprostanes (IsoPs)] were measured. RESULTS: Twenty subjects were categorized as 0 (no risk), 24 as 1 (intermediate risk) and 20 as 2 (severe risk) based on their CHADS-2 scores. High sensitivity-CRP (CHADS-2 0=40.0%, 1=70.0%, 2=90.0%; p=0.003) and DROMs (CHADS-2 0=45%, 1=78%, 2=80%; p=0.04) were positively associated with the CHADS-2 risk score. Subjects with intermediate to severe CHADS-2 risk retained significant associations with abnormal hs-CRP (OR: 5.3, 95%CI: 1.1-25.0) and DROMs (adjusted OR: 6.7, 95%CI: 1.2-38.8) after adjusting for gender and hypertension. In a multiple logistic interaction model, there was no significant interaction between hs-CRP and DROMs in their association with CHADS-2 risk categories (p=0.64). A biomarker risk-model, combining hs-CRP and DROMs, correlated well with the CHADS-2 risk categories (r= 0.49, p<0.001). CONCLUSIONS: A biomarker risk-model using a combination of hs-CRP and DROMs correlates well with CHADS-2 risk scores in chronic AF. Either or both of these markers may add predictive power to future stroke risk prediction models.
Authors: Margaret C Fang; Alan S Go; Yuchiao Chang; Leila H Borowsky; Niela K Pomernacki; Natalia Udaltsova; Daniel E Singer Journal: J Am Coll Cardiol Date: 2011-07-19 Impact factor: 24.094
Authors: José Hermida; Faye L Lopez; Ramón Montes; Kunihiro Matsushita; Brad C Astor; Alvaro Alonso Journal: Am J Cardiol Date: 2011-09-29 Impact factor: 2.778
Authors: V Roldán; F Marín; J Díaz; P Gallego; E Jover; M Romera; S Manzano-Fernández; T Casas; M Valdés; V Vicente; G Y H Lip Journal: J Thromb Haemost Date: 2012-08 Impact factor: 5.824
Authors: Hua Cai; Zongming Li; Andreas Goette; Fernando Mera; Clegg Honeycutt; Kristian Feterik; Josiah N Wilcox; Samuel C Dudley; David G Harrison; Jonathan J Langberg Journal: Circulation Date: 2002-11-26 Impact factor: 29.690
Authors: Samuel C Dudley; Nyssa E Hoch; Louise A McCann; Clegg Honeycutt; Laura Diamandopoulos; Tohru Fukai; David G Harrison; Sergey I Dikalov; Jonathan Langberg Journal: Circulation Date: 2005-08-30 Impact factor: 29.690
Authors: Sarah C W Marott; Børge G Nordestgaard; Jeppe Zacho; Jens Friberg; Gorm B Jensen; Anne Tybjaerg-Hansen; Marianne Benn Journal: J Am Coll Cardiol Date: 2010-08-31 Impact factor: 24.094
Authors: Young M Kim; Hassan Kattach; Chandi Ratnatunga; Ravi Pillai; Keith M Channon; Barbara Casadei Journal: J Am Coll Cardiol Date: 2008-01-01 Impact factor: 24.094